Amiodarone-induced hyperthyroidism and a thyroid nodule.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
C N MorrisS A Smith

Abstract

To report two cases of thyrotoxicosis associated with amiodarone therapy and to discuss how the presence of a thyroid nodule alters management. We describe two patients with amiodarone-induced hyperthyroidism, review the mechanisms of disease, and outline a strategy for decision making relative to treatment in the presence of a thyroid nodule. Amiodarone-induced thyrotoxicosis occurs by two mechanisms: a direct toxic effect and iodine loading. This condition may be treated medically or surgically, but when discontinuation of amiodarone therapy is not possible and medical management is ineffective, surgical therapy is often necessary. The optimal presurgical management in the cases described required the use of thyroid scanning to determine whether the disease process was attributable to a hyperfunctioning nodule or generalized. The findings were helpful in planning the extent of surgical excision. When surgical treatment is planned for patients with a solitary thyroid nodule and amiodarone-induced hyperthyroidism, preoperative thyroid scanning will direct the surgeon to perform either subtotal thyroidectomy for diffuse disease or lobectomy for a hyperfunctioning nodule.

References

Dec 15, 1989·Biochemical Pharmacology·S A BeddowsS S Nussey
Jan 1, 1983·Medicine·J E Fradkin, J Wolff
Jul 1, 1984·Annals of Internal Medicine·E MartinoC Haffajee

❮ Previous
Next ❯

Citations

Apr 8, 2004·Thyroid : Official Journal of the American Thyroid Association·Laura E RyanRichard T Kloos
May 18, 2010·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Nicole V TilluckdharryCaroline S Kim

❮ Previous
Next ❯

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Related Papers

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Susan R BrianPhilip A Goldberg
Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine
Brian D Phillips, James V Hennessey
Endocrine-related Cancer
Dheeraj KaramchandaniKlaus-Martin Schulte
© 2022 Meta ULC. All rights reserved